IL32 and HIV infectious disease: Furthermore, targeted reduction of IL-32 expression and, consequently, its secretion by T cells could favor patients suffering from diseases, in which T cells are the major IL-32 producers, like HIV-infection, beta cell autoimmunity and cancer (8–10).